Alice Zhang, CEO and Co-Founder of Verge Genomics, leads a pioneering therapeutics company. Verge Genomics uses patient data to uncover innovative treatments for challenging diseases, mainly focusing on neurodegenerative conditions. Alice's remarkable work has gained recognition from esteemed publications like the San Francisco Business Times, MIT Technology Review, and Forbes, positioning her as a prominent young innovator.
Before establishing Verge, Alice researched groundbreaking systems biology at prestigious institutions, including the National Cancer Institute, Princeton University, and UCLA. With a bachelor's degree in Molecular Biology from Princeton University, she was honored with the Paul & Daisy Soros Fellowship for New Americans. Apart from her role at Verge, Alice engages in angel investing and advising for startups at the technology-biology crossroads.
Alice Zhang shares insights into disrupting the system, treating the untreatable with AI, therapeutics, life sciences, biotech, pharma, CNS and neurodegeneration, being a young female founder and CEO, working with VC and investors, diversity and inclusion, and start up related challenges.
Would you like a workshop customised to meet your organisation’s specific needs and hosted by your chosen expert? Designed for your use case and supported by experienced facilitators, these interactive programs combine theory with real-world experience and provide leaders with practical skills that can be immediately applied. This approach fosters authentic behavioural change, improves leadership capabilities, and upskills your people across various subject areas. Get in touch with PepTalk today to learn how your team can benefit.
